Mental Health/Telehealth Organizations AMSOCI to AMSOCIFZ

Mental Health and Telehealth Organizations
And Professional Events AMSOCI to AMSOCIFZ

For events of organizations other than AMSOCI- to AMSOCIFZ- click HERE.

For events listed by date click HERE.

For events listed by city click HERE.

Organization and Event Details

<--Click for table of contents.

American Society of Addiction Medicine [ASAM] (If you wish to, click above for the organization's home page)
Contact:	(The link below is available for securing more information) American Society of Addiction Medicine 4601 North Park Avenue Upper Arcade, Suite 101 Chevy Chase, MD 20815-4520 301/656-3920 301/656-3815 fax asamoffice@aol.com
About:	The American Society of Addiction Medicine [ASAM], a non-profit organization, is the nation's largest medical specialty society dedicated to educating physicians and improving the treatment of the 17 percent of the population suffering from alcoholism or other addictions. There are 28 state chapters associated with the national society. Goals: Increase access to and improve the quality of addictions treatment Develop standards for addiction care Educate physicians, medical students, and the public Advocate for proper care of patients who suffer from addictive disease Establish addiction medicine as a specialty recognized by the American Board of Medical Specialties Society publications include: Journal of Addictive Disease (quarterly) ASAM News (bimonthly) ASAM Patient Placement Criteria for the Treatment of Substance Related Disorders, Second Edition with optional hypertext software Review Course Syllabus Practice Guidelines Series Principles of Addiction Medicine Topics in Addiction Medicine ASAM Public Policy Statements
Event List:	Buprenorphine & Office Based Treatment of Opioid Dependence October 6, 2007: Indianapolis, IN Buprenorphine & Office Based Treatment of Opioid Dependence October 14, 2007: New York, NY Buprenorphine & Office Based Treatment of Opioid Dependence October 20, 2007: San Diego, CA Buprenorphine & Office Based Treatment of Opioid Dependence October 28, 2007: Washington, DC
Event #1 Detail:	Buprenorphine & Office Based Treatment of Opioid Dependence (Please refer to the meeting's Web pages.) October 6, 2007 Indianapolis, IN Event sponsored by: American Society of Addiction Medicine [ASAM] Topics: Overview of Opioid Dependence Rationale for Opioid Agonist Treatment Legislative Changes Allowing Office-Based Treatment of Opioid Dependence, Including the Drug Addiction Treatment Act of 2000 General Opioid Pharmacology Pharmacology of Buprenorphine and Buprenorphine / Naloxone Efficacy and Safety of Buprenorphine / Naloxone Clinical Use of Buprenorphine / Naloxone, Including Induction, Maintenance, and Pharmacological Withdrawal Patient Assessment and Selection Office Procedures and Logistics Psychiatric Co-Morbidity in Opioid Dependent Patients Medical Co-Morbidity in Opioid Dependent Patients The Role of Psychosocial Counseling in the Treatment of Opioid Dependence Special Treatment Populations, Including the Management of Patients who Develop Pain while Receiving Buprenorphine / Naloxone, Pregnancy and Adolescents Faculty: Petros Levounis, MD, MA, Director, The Addiction Institute of New York; Chief, Division of Addiction Psychiatry, St Luke's & Roosevelt Hospitals; Assistant Professor of Clinical Psychiatry, Columbia University College of Physicians & Surgeons, New York, New York Gary P Katzman, MD, Clinical Assistant Professor, Department of Psychiatry, Mt Sinai School of Medicine, New York, New York Edwin A Salsitz, MD, FASAM, Medical Director, Office-Based Opioid Therapy, Department of Medicine, Beth Israel Medical Center, New York, New York As many as 8 continuing education credit hours available for -physicians Event Contact: (you can activate the link below for more detail) Opt-In PO Box 378 Sea Girt, NJ 08750 888/362-6784 732/919-2685 fax (A request: when asking about the above meeting, would you be nice and refer to this World Wide Web resource as your source?)
Event #2 Detail:	Buprenorphine & Office Based Treatment of Opioid Dependence (You can refer to the meeting's Web pages.) October 14, 2007 New York, NY Sponsored by: American Society of Addiction Medicine [ASAM] Topics: Overview of Opioid Dependence Rationale for Opioid Agonist Treatment Legislative Changes Allowing Office-Based Treatment of Opioid Dependence, Including the Drug Addiction Treatment Act of 2000 General Opioid Pharmacology Pharmacology of Buprenorphine and Buprenorphine / Naloxone Efficacy and Safety of Buprenorphine / Naloxone Clinical Use of Buprenorphine / Naloxone, Including Induction, Maintenance, and Pharmacological Withdrawal Patient Assessment and Selection Office Procedures and Logistics Psychiatric Co-Morbidity in Opioid Dependent Patients Medical Co-Morbidity in Opioid Dependent Patients The Role of Psychosocial Counseling in the Treatment of Opioid Dependence Special Treatment Populations, Including the Management of Patients who Develop Pain while Receiving Buprenorphine / Naloxone, Pregnancy and Adolescents There are as many as 8 continuing education credit hours available for -physicians Event Contact: (you can use the link below for more information) Opt-In PO Box 378 Sea Girt, NJ 08750 888/362-6784 732/919-2685 fax (As a courtesy: please point out that you learned about it in these pages when inquiring about the above meeting.)
Event #3 Detail:	Buprenorphine & Office Based Treatment of Opioid Dependence (Please consult the meeting's Web pages.) October 20, 2007 San Diego, CA Event sponsor: American Society of Addiction Medicine [ASAM] Topics: Overview of Opioid Dependence Rationale for Opioid Agonist Treatment Legislative Changes Allowing Office-Based Treatment of Opioid Dependence, Including the Drug Addiction Treatment Act of 2000 General Opioid Pharmacology Pharmacology of Buprenorphine and Buprenorphine / Naloxone Efficacy and Safety of Buprenorphine / Naloxone Clinical Use of Buprenorphine / Naloxone, Including Induction, Maintenance, and Pharmacological Withdrawal Patient Assessment and Selection Office Procedures and Logistics Psychiatric Co-Morbidity in Opioid Dependent Patients Medical Co-Morbidity in Opioid Dependent Patients The Role of Psychosocial Counseling in the Treatment of Opioid Dependence Special Treatment Populations, Including the Management of Patients who Develop Pain while Receiving Buprenorphine / Naloxone, Pregnancy and Adolescents There are as many as 8 continuing education credit hour equivalents available for -physicians Event Contact: (the link below is available for securing more information) Opt-In PO Box 378 Sea Girt, NJ 08750 888/362-6784 732/919-2685 fax (Please, if inquiring about this, don't forget to mention these Web pages.)
Event #4 Detail:	Buprenorphine & Office Based Treatment of Opioid Dependence (Kindly see the meeting's Web pages.) October 28, 2007 Washington, DC Event sponsored by: American Society of Addiction Medicine [ASAM] Topics: Overview of Opioid Dependence Rationale for Opioid Agonist Treatment Legislative Changes Allowing Office-Based Treatment of Opioid Dependence, Including the Drug Addiction Treatment Act of 2000 General Opioid Pharmacology Pharmacology of Buprenorphine and Buprenorphine / Naloxone Efficacy and Safety of Buprenorphine / Naloxone Clinical Use of Buprenorphine / Naloxone, Including Induction, Maintenance, and Pharmacological Withdrawal Patient Assessment and Selection Office Procedures and Logistics Psychiatric Co-Morbidity in Opioid Dependent Patients Medical Co-Morbidity in Opioid Dependent Patients The Role of Psychosocial Counseling in the Treatment of Opioid Dependence Special Treatment Populations, Including the Management of Patients who Develop Pain while Receiving Buprenorphine / Naloxone, Pregnancy and Adolescents There are as many as 8 continuing education credit hour equivalents available for -physicians Event Contact: (you might use the link below for e-mail) Opt-In PO Box 378 Sea Girt, NJ 08750 888/362-6784 732/919-2685 fax (If you please, it could be very nice of you to tell about this World Wide Web resource when you call to inquire about this event.)

<--Click here for table of contents.

American Society for Adolescent Psychiatry [ASAP] (You can click on the above for the organization home page)
Contact:	(You might activate the link below for more information) American Society for Adolescent Psychiatry PO Box 570218 Dallas, TX 75357-0218 888/877-4311 972/686-6166 972/613-5532 fax info@adolpsych.org
About:	The American Society for Adolescent Psychiatry [ASAP] is a professional association of psychiatrists with an active interest in adolescence, adolescents and young adults. Founded in 1967, ASAP is a federation of 15 constituent societies throughout the United States and Canada.

<--Click here for table of contents for organizations AMSOCI- to AMSOCIFZ.

American Society on Aging [ASA] (Please click above for the organization home page)
Contact:	(You might click on the link for e-mail) American Society on Aging 833 Market Street Suite 511 San Francisco, CA 94103-1824 415/974-9600 415/974-0300 fax info@asa.asaging.org
About:	The American Society on Aging [ASA] is a nonprofit membership organization that informs the public and health professionals about issues affecting the quality of life for older people and promotes innovative approaches to meet these needs.

<--Click here for table of contents for this page.

American Society of Clinical Hypnosis [ASCH] (You can click above for its home page)
Contact:	(You might click on the link below for e-mail) American Society of Clinical Hypnosis 130 East Elm Court Suite 201 Roselle, IL 60172-2000 630/980-4740 630/351-8490 fax 847/297-3317 847/297-7309 fax info@asch.net
About:	The American Society of Clinical Hypnosis [ASCH] is a not-for-profit organization of professional people in medicine, dentistry, psychology, social work, nursing, and mental health who share scientific and clinical interests in hypnosis. Its purpose is to provide and encourage education programs to further, in every ethical way, the knowledge and understanding of hypnosis. It stimulates research and encourages scientific publication in the field of hypnosis and promotes the acceptance of hypnosis as an important tool of ethical clinical practice and scientific research and cooperates with other professional societies that share mutual goals, ethics and interests. The official journal of ASCH is the American Journal of Clinical Hypnosis.

American Society of Clinical Hypnosis [ASCH]

(You can click above for its home page)

Contact:

(You might click on the link below for e-mail)
American Society of Clinical Hypnosis
130 East Elm Court
Suite 201
Roselle, IL 60172-2000

630/980-4740
630/351-8490 fax

847/297-3317
847/297-7309 fax

info@asch.net

About:

The American Society of Clinical Hypnosis [ASCH] is a not-for-profit organization of professional people in medicine, dentistry, psychology, social work, nursing, and mental health who share scientific and clinical interests in hypnosis. Its purpose is to provide and encourage education programs to further, in every ethical way, the knowledge and understanding of hypnosis. It stimulates research and encourages scientific publication in the field of hypnosis and promotes the acceptance of hypnosis as an important tool of ethical clinical practice and scientific research and cooperates with other professional societies that share mutual goals, ethics and interests.

The official journal of ASCH is the American Journal of Clinical Hypnosis.

<--Click for table of contents for organizations AMSOCI- to AMSOCIFZ.

American Society for Clinical Pharmacology and Therapeutics [ASCPT] (If you please, click on the above for its home page)
Contact:	(You can click on the link below for obtaining more detail) American Society for Clinical Pharmacology and Therapeutics 528 North Washington Street Alexandria, VA 22314 703/836-6981 703/836-5223 fax info@ascpt.org
About:	The American Society for Clinical Pharmacology and Therapeutics [ASCPT] was founded in 1900. It consists of over 2,200 professionals whose primary interest is to promote and advance the science of human pharmacology and therapeutics. ASCPT is the largest scientific and professional organization serving the discipline of Clinical Pharmacology.

<--Click for table of contents.

American Society of Clinical Psychopharmacology [ASCP] (If you please, click above for its home page)
Contact:	(You can use the link below for making contact) American Society of Clinical Psychopharmacology PO Box 40395 Glen Oaks, NY 11004 718/470-4007 718/343-7739 fax jrusso@lij.edu
About:	The non-profit American Society of Clinical Psychopharmacology [ASCP] was formed in 1992 to advance the science and practice of clinical psychopharmacology. Objectives: Support and encourage clinically relevant research in psychopharmacology and the rapid dissemination of new findings Facilitate exchange of information among senior psychopharmacologists and other investigators in the field and the exchange of information and discussion between investigators and practitioners of psychopharmacology Stimulate and encourage young investigators interested in psychopharmacology Provide continuing education, e.g., reviews, updates, presentation of new findings, for practicing psychopharmacologists Provide basic instruction for health professionals interested in psychopharmacology Encourage interest in and support training in psychopharmacology for medical students, psychiatric residents and fellows Establish liaisons with, and complement the efforts of, other related professional organizations, eg, APA, ACNP, Biological Psychiatry Provide educational programs on the treatment of psychiatric disorders for patients and families and to encourage interchange between psychopharmacologists and patients and their families Develop constructive relationships with mental health advocacy groups Advocate public policies which promote clinical research of psychiatric disorders and the delivery of high quality patient care The official journal of ASCP is the Journal of Clinical Psychiatry.

American Society of Clinical Psychopharmacology [ASCP]

(If you please, click above for its home page)

Contact:

(You can use the link below for making contact)
American Society of Clinical Psychopharmacology
PO Box 40395
Glen Oaks, NY 11004

718/470-4007
718/343-7739 fax

jrusso@lij.edu

About:

The non-profit American Society of Clinical Psychopharmacology [ASCP] was formed in 1992 to advance the science and practice of clinical psychopharmacology.

Objectives:

Support and encourage clinically relevant research in psychopharmacology and the rapid dissemination of new findings
Facilitate exchange of information among senior psychopharmacologists and other investigators in the field and the exchange of information and discussion between investigators and practitioners of psychopharmacology
Stimulate and encourage young investigators interested in psychopharmacology
Provide continuing education, e.g., reviews, updates, presentation of new findings, for practicing psychopharmacologists
Provide basic instruction for health professionals interested in psychopharmacology
Encourage interest in and support training in psychopharmacology for medical students, psychiatric residents and fellows
Establish liaisons with, and complement the efforts of, other related professional organizations, eg, APA, ACNP, Biological Psychiatry
Provide educational programs on the treatment of psychiatric disorders for patients and families and to encourage interchange between psychopharmacologists and patients and their families
Develop constructive relationships with mental health advocacy groups
Advocate public policies which promote clinical research of psychiatric disorders and the delivery of high quality patient care

The official journal of ASCP is the Journal of Clinical Psychiatry.

<--Go to table of contents for organizations AMSOCI- to AMSOCIFZ.

American Society for Experimental Neurotherapeutics [ASENT] (You can click above for the organization home page)
Contact:	(The link below is available for e-mail) American Society for Experimental Neurotherapeutics 611 East Wells Street ]Milwaukee, WI 53202 414/273-8290 414/276-3349 fax info@asent.org
About:	Objectives: Provide a forum for the broadly defined interest areas of academia, government, and industry concerned with the field of neurotherapeutics Promote dialog, understanding, and cooperation among the interested groups Develop information and seek consensus on matters germane to the organization's mission Organize education and training for healthcare practitioners, biomedical scientists, and officials participating in the neurotherapeutics field The official publication of ASENT is NeuroRx.

American Society for Experimental Neurotherapeutics [ASENT]

(You can click above for the organization home page)

Contact:

(The link below is available for e-mail)
American Society for Experimental Neurotherapeutics
611 East Wells Street
]Milwaukee, WI 53202

414/273-8290
414/276-3349 fax

info@asent.org

About:

Objectives:

Provide a forum for the broadly defined interest areas of academia, government, and industry concerned with the field of neurotherapeutics
Promote dialog, understanding, and cooperation among the interested groups
Develop information and seek consensus on matters germane to the organization's mission
Organize education and training for healthcare practitioners, biomedical scientists, and officials participating in the neurotherapeutics field

The official publication of ASENT is NeuroRx.

想加入您的組織或開會日期請聯絡 Dr. Pulier.

回首頁

精神醫學園地-全球精神醫學園地-台灣心靈園地心靈診所心靈書坊歡迎登錄 Mirror

Updated 9:48:53 PM 9/30/2007 EDT
PsychPark is edited by Chao-Cheng Lin, MD

精神衛生機構搜尋器
搜尋"AMSOCI - AMSOCIFZ"開頭之機構

Related Pages

Table of Contents

Organization and Event Details

精神衛生機構搜尋器 搜尋"AMSOCI - AMSOCIFZ"開頭之機構

Related Pages

Table of Contents

Organization and Event Details

精神衛生機構搜尋器
搜尋"AMSOCI - AMSOCIFZ"開頭之機構